Gary Lichtenstein, MD, FACG

Perelman Center for Advanced Medicine, University of Pennsylvania

Poster(s):

• P2682 - Impact of Baseline Disease Duration on Ozanimod Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 True North Study
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET